Refoxy Pharmaceuticals raises €9.1M Seed round
4 December 2024· Cologne, Germany· health, biotech, ai, b2b, deep_hardware
The financing will accelerate the preclinical development of Refoxy's program in idiopathic pulmonary fibrosis (IPF) and expand its platform to other age-related indications.
Investors
LeadBoehringer Ingelheim Venture Fund
Also participating
High-Tech GründerfondsApollo Health VenturesNRW.Venture
About Refoxy Pharmaceuticals
Stage
Seed
Headquarters
Cologne, Germany
Founded
2020
Team Size
6–20
Sectors
healthbiotechaib2bdeep_hardware